CA2852386C - Systeme de gelification in situ absorbable, son procede de fabrication et son utilisation - Google Patents

Systeme de gelification in situ absorbable, son procede de fabrication et son utilisation Download PDF

Info

Publication number
CA2852386C
CA2852386C CA2852386A CA2852386A CA2852386C CA 2852386 C CA2852386 C CA 2852386C CA 2852386 A CA2852386 A CA 2852386A CA 2852386 A CA2852386 A CA 2852386A CA 2852386 C CA2852386 C CA 2852386C
Authority
CA
Canada
Prior art keywords
forming composition
situ gel
lactide
gel
glycolide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2852386A
Other languages
English (en)
Other versions
CA2852386A1 (fr
Inventor
Shalaby W. Shalaby
Joel Corbett
Jason OLBRICH
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Poly Med Inc
Original Assignee
Poly Med Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Poly Med Inc filed Critical Poly Med Inc
Publication of CA2852386A1 publication Critical patent/CA2852386A1/fr
Application granted granted Critical
Publication of CA2852386C publication Critical patent/CA2852386C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0031—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0015—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0042—Materials resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/36—Materials or treatment for tissue regeneration for embolization or occlusion, e.g. vaso-occlusive compositions or devices

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Surgery (AREA)
  • Materials Engineering (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dispersion Chemistry (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

L'invention concerne une composition gélifiante in situ. La composition gélifiante in situ comprend au moins un polymère absorbable, des solvants tels que la N-méthyl-2-pyrrolidone, le polyéthylène glycol ou le DMSO, et facultativement au moins un agent bioactif. La composition forme un hydrogel ou une masse semi-solide lors de sa mise en contact avec un environnement aqueux. L'invention concerne également la méthode d'utilisation de la composition gélifiante in situ dans le cadre de diverses applications.
CA2852386A 2011-10-17 2011-10-17 Systeme de gelification in situ absorbable, son procede de fabrication et son utilisation Active CA2852386C (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2011/056537 WO2013058726A1 (fr) 2011-10-17 2011-10-17 Système de gélification in situ absorbable, son procédé de fabrication et son utilisation

Publications (2)

Publication Number Publication Date
CA2852386A1 CA2852386A1 (fr) 2013-04-25
CA2852386C true CA2852386C (fr) 2019-05-21

Family

ID=48141188

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2852386A Active CA2852386C (fr) 2011-10-17 2011-10-17 Systeme de gelification in situ absorbable, son procede de fabrication et son utilisation

Country Status (5)

Country Link
EP (1) EP2768544A4 (fr)
JP (1) JP5989126B2 (fr)
CN (2) CN103998069A (fr)
CA (1) CA2852386C (fr)
WO (1) WO2013058726A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150305892A1 (en) * 2014-04-25 2015-10-29 Abbott Cardiovascular Systems Inc. Methods and Devices for Treating a Bodily Lumen with In Situ Generated Structural Support
CN104189951B (zh) * 2014-09-19 2017-06-30 赣南师范学院 一种注射用快速形成原位小分子水凝胶的液态制剂及其制备方法和应用
CN104383276A (zh) * 2014-10-27 2015-03-04 济南高达信息技术有限公司 一种治疗蜘蛛痣的中药口服液制剂及其制备方法
EP3804698B1 (fr) * 2015-08-03 2024-01-31 Tolmar International Limited Système de distribution de polymère liquide pour l'administration prolongée de médicaments
CN108289844B (zh) * 2015-11-16 2021-09-14 赢创运营有限公司 包含非核苷逆转录酶抑制剂和聚(丙交酯-共-乙交酯)的注射溶液
CN110087705B (zh) * 2016-05-03 2022-08-05 Bvw控股公司 多相凝胶
CA3133348A1 (fr) * 2019-03-15 2020-09-24 Poly-Med, Inc. Systemes d'administration, methodes et compositions formant un gel in situ

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6413539B1 (en) * 1996-10-31 2002-07-02 Poly-Med, Inc. Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof
EP0842209B1 (fr) * 1995-07-28 2006-10-11 Genzyme Corporation Hydrogels multiblocs biodegradables destines a etre utilises comme agents de liberation regulee pour l'administration de medicaments et le traitement de tissus
ATE269121T1 (de) * 1996-07-29 2004-07-15 Micro Therapeutics Inc Kit aus drei glasfläschen zur vaskulären embolisierung unter verwendung eines dimethylsulfoxyd enthaltenden mittels
US5854382A (en) * 1997-08-18 1998-12-29 Meadox Medicals, Inc. Bioresorbable compositions for implantable prostheses
JP2002519333A (ja) * 1998-06-30 2002-07-02 アムジエン・インコーポレーテツド 生物学的に活性な物質の徐放運搬のための感熱性生分解性ヒドロゲル
US6245740B1 (en) * 1998-12-23 2001-06-12 Amgen Inc. Polyol:oil suspensions for the sustained release of proteins
EP1987847A1 (fr) * 1999-05-21 2008-11-05 Micro Therapeutics, Inc. Nouvelles compositions d'embolisation haute viscosité
US7649023B2 (en) * 2002-06-11 2010-01-19 Novartis Ag Biodegradable block copolymeric compositions for drug delivery
AU2003272011A1 (en) * 2002-10-31 2004-05-25 Pfizer Products Inc. Solid and semi-solid polymeric ionic conjugates
CN1950114A (zh) * 2004-05-12 2007-04-18 苏尔莫迪克斯公司 用于医疗物品的天然生物可降解的多糖涂层
US20050255091A1 (en) * 2004-05-14 2005-11-17 Loomis Gary L Hydrogels for biomedical applications
CN1899264A (zh) * 2006-07-20 2007-01-24 上海交通大学 温度敏感型水凝胶释药体系及其制备方法
CN100562358C (zh) * 2007-05-17 2009-11-25 浙江大学 以水凝胶微球为模板制备中空微球的方法
US20090233887A1 (en) * 2008-03-12 2009-09-17 Shalaby Shalaby W Hydroswellable, Segmented, Aliphatic Polyurethanes and Polyurethane Ureas
CN101721349B (zh) * 2008-10-16 2011-07-20 常州百瑞吉生物医药有限公司 可注射原位交联水凝胶及其制备方法和用途
CN102146200B (zh) * 2011-04-19 2012-08-22 复旦大学 一种基于化学交联凝胶颗粒的温敏性水凝胶及其制备方法

Also Published As

Publication number Publication date
CN107252498A (zh) 2017-10-17
EP2768544A4 (fr) 2015-06-24
EP2768544A1 (fr) 2014-08-27
CA2852386A1 (fr) 2013-04-25
JP5989126B2 (ja) 2016-09-07
WO2013058726A1 (fr) 2013-04-25
CN107252498B (zh) 2021-02-19
CN103998069A (zh) 2014-08-20
JP2014532082A (ja) 2014-12-04

Similar Documents

Publication Publication Date Title
US20190167839A1 (en) Absorbable in situ gel-forming system, method of making and use thereof
Domb et al. Biodegradable polymers in clinical use and clinical development
Gong et al. Thermosensitive PEG–PCL–PEG hydrogel controlled drug delivery system: sol–gel–sol transition and in vitro drug release study
Xu et al. Accelerated cutaneous wound healing using an injectable teicoplanin-loaded PLGA-PEG-PLGA thermogel dressing
Yu et al. Biodegradability and biocompatibility of thermoreversible hydrogels formed from mixing a sol and a precipitate of block copolymers in water
Guo et al. Thermosensitive polymer hydrogel as a physical shield on colonic mucosa for colitis treatment
KR101263520B1 (ko) 가역성 열적 겔화 특성을 나타내는 생물분해성 이중블록공중합체 및 이의 사용 방법
CN107252498B (zh) 可吸收的原位凝胶形成系统、其制备方法及用途
CA2672551C (fr) Compositions copolymeres bloc biodegradables destinees a l'administration de medicaments
Yu et al. Poly (lactic acid-co-glycolic acid)–poly (ethylene glycol)–poly (lactic acid-co-glycolic acid) thermogel as a novel submucosal cushion for endoscopic submucosal dissection
CA3067269C (fr) Compositions de pate polymere pour administration de medicament
US20050238722A1 (en) Multiblock biodegradable hydrogels for drug delivery and tissue treatment
Nagahama et al. Biodegradable polymers exhibiting temperature-responsive sol–gel transition as injectable biomedical materials
CN101557802B (zh) 自凝固的可生物蚀解的屏障植入物
CA2726763A1 (fr) Formulation copolymerique a liberation controlee presentant une cinetique de liberation amelioree
CN101862454A (zh) 一种物理交联的水凝胶组合物及其制备方法和应用
EP3901193A1 (fr) Polymère modifié par un acide aminé pour la prévention de l'adhésion et son application
CN107811965A (zh) 一种缓释巴马司他的聚酯－聚醚温敏凝胶制剂及制备方法
EP2997982A1 (fr) Substance pour la prévention des adhérences et son procédé de fabrication
CA3167259A1 (fr) Compositions polymeres mucoadhesives d'administration de medicament et procedes
CN115403760B (zh) 用于预防沾粘的氨基酸改质的聚合物及其应用
Ohya Injectable Hydrogels
Hydrogels Injectable Temperature-and pH| Temperature-Sensitive Block
CN109966316A (zh) 粉体制剂与水凝胶组合物用于制备减缓退化性关节及修复肌腱断裂的药物的用途

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20161007

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 13TH ANNIV.) - STANDARD

Year of fee payment: 13

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20240927

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20240927

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20240927

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-4-4-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20251201